Attract talent

Q32 Bio

1 Follower


Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.


Add photos to showcase Q32 Bio’s culture


Add Q32 Bio’s values

Insider experiences

Share your experience of working at Q32 Bio

Michael Broxson
CEO & Director
Shelia Violette
Co-Founder & Chief Scientific Officer
Jason Campagna
Chief Medical Officer
Debra Segal
VP of Regulatory Affairs
Maria Marzilli
VP of Corporate Development & Program Management

Add your teams to show how people work together at Q32 Bio

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.